Alpha Profiles · Company Profile

Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies.

https://registry.alpha.ac/companies/medtronic-plc

Entity: Public listing published
Primary listing: NYSE: MDT
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:02.867545+00:00

Overview

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrill

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

8 public records

Brett Wall

Executive Vice President and President, Neuroscience Portfolio

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Geoffrey S. Martha

Chairman and Chief Executive Officer

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Gregory L. Smith

Executive Vice President, Enterprise Operations

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Ivan K. Fong

Executive Vice President, General Counsel and Secretary

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Matthew Walter

Senior Vice President, Chief Human Resources Officer

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Michael Marinaro

Executive Vice President and President, Medical Surgical Portfolio and Americas

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Skip Kiil

Executive Vice President and President, Cardiovascular Portfolio

State: confirmed
Effective: From Jun 20, 2025
Confidence: 94%
Evidence: MDT 10-K executive officersJun 20, 2025

Thierry Pi ton

Executive Vice President and Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: MDT executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.